Global coalition to accelerate COVID-19 clinical research in resource-limited settings

The Lancet

Volumn 395, Issue 10233, 2020, Pages 1322-1325

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); CORONAVIRUS DISEASE 2019; CORONAVIRUS INFECTION; DIAGNOSTIC TEST; EBOLA HEMORRHAGIC FEVER; EVIDENCE BASED MEDICINE; FUNDING; GOVERNMENT REGULATION; HEALTH CARE AVAILABILITY; HEALTH CARE NEED; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH SERVICE; HUMAN; INFECTION RATE; INTERNATIONAL COOPERATION; MEDICAL ETHICS; NOTE; POLITICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC-PRIVATE PARTNERSHIP; SARS-RELATED CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; VIRUS PNEUMONIA;

EID: 85082810368     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(20)30798-4     Document Type: Note

References (12)

1. Maguire, BJ, Guérin, PJ, A living systematic review protocol for COVID-19 clinical trial registrations. Wellcome Open Res, 2020 published online April 2. https://doi.org/10.12688/wellcomeopenres.15821.1.
2. Infectious Diseases Data Observatory (IDDO), University of Oxford, UK. Living systematic review COVID-19. Coronavirus disease 2019 registered clinical trials. https://www.iddo.org/research-themes/covid-19/live-systematic-clinical-trial-review, 2020. (Accessed 31 March 2020)
3. WHO. Coronavirus disease 2019 (COVID-19). Situation report—71. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200331-sitrep-71-covid-19.pdf?sfvrsn=4360e92b_6, March 31, 2020. (Accessed 1 April 2020)
4. Wellcome. Wellcome pledges up to $50 million to new initiative to speed development of COVID-19 treatments. https://wellcome.ac.uk/news/wellcome-pledges-50-million-new-initiative-speed-development-covid-19-treatments, March 9, 2020. (Accessed 31 March 2020)
5. WHO. WHO Director-General's opening remarks at the media briefing on COVID-19. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—18-march-2020, March 18, 2020. (Accessed 31 March 2020)
6. WHO. A coordinated global research roadmap: 2019 novel coronavirus. 2020, World Health Organization, Geneva https://www.who.int/blueprint/priority-diseases/key-action/Coronavirus_Roadmap_V9.pdf?ua=1. (Accessed 31 March 2020)
7. Baud, D, Qi, X, Nielsen-Saines, K, Musso, D, Pomar, L, Favre, G, Real estimates of mortality following COVID-19 infection. Lancet Infect Dis, 2020 published online March 12. https://doi.org/10.1016/S1473-3099(20)30195-X.
8. Nuffield Council on Bioethics. Research in global health emergencies: ethical issues. https://www.nuffieldbioethics.org/assets/pdfs/RGHE_full_report1.pdf, Jan 28, 2020. (Accessed 31 March 2020)
9. Nuffield Council on Bioethics. Ethical considerations in responding to the COVID-19 pandemic. https://www.nuffieldbioethics.org/assets/pdfs/Ethical-considerations-in-responding-to-the-COVID-19-pandemic.pdf, March 17, 2020. (Accessed 31 March 2020)
10. Wilson, ML, Fleming, KA, Kuti, MA, Looi, LM, Lago, N, Ru, K, Access to pathology and laboratory medicine services: a crucial gap. Lancet 391 (2018), 1927–1938.
11. Nature. COVID-19: what science advisers must do now. Nature 579 (2020), 319–320.
12. Wilkinson, M, Dumontier, M, Aalbersberg, I, et al. The FAIR Guiding Principles for scientific data management and stewardship. Sci Data, 3, 2016, 160018.